2021 Influenza Vaccine and COVID-19 Vaccine Update

You are invited to a live educational webcast for healthcare professionals. Please join us 24th February 2021, when we launch FLUcELVAX QUAD, the first cell-based influenza vaccine available in Australia. This live webcast will also provide an update on COVID-10 vaccines, and will feature three key speakers:

• Dr Russell Basser
  Senior Vice President, Research & Development, will discuss Seqirus’ commitment to innovation and the development of influenza vaccine cell technology.
• Prof. Robert Booy
  Infectious diseases and immunisation expert, outlines the clinical profile of FLUCELVAX QUAD.
• Dr Jonathan Anderson
  Head of Seqirus Medical Affairs, Asia Pacific, discusses the 2020 & 2021 influenza seasons, and provides an update on COVID-19 vaccines.